Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Annals of Surgical Oncology|April 24, 2014
Sentinel lymph node biopsy in pregnant women with breast cancerAdrienne B Gropper, Katherina Zabicki Calvillo, Laura Dominici, et al.Clinical Nuclear Medicine|June 6, 2025
Negative 18 F-FES PET/CT Despite Estrogen Receptor Positivity by ImmunohistochemistryIsmaheel O Lawal, Xiaoxian Li, Elizabeth A Sakach, et al.European Journal of Nuclear Medicine and Molecular Imaging|July 8, 2024
Prospective investigation of amino acid transport and PSMA-targeted positron emission tomography for metastatic lobular breast carcinomaAliza Mushtaq, Ismaheel O Lawal, Saima Muzahir, et al.Contemporary Clinical Trials|November 20, 2025
Improving CDK4/6 inhibitors adherence in breast cancer using the CONnected CUstomized Treatment Platform (CONCURxP) mobile health intervention: Study protocol for ECOG-ACRIN EAQ221CDGelareh Sadigh, Fenghai Duan, Ilana F Gareen, et al.Clinical Breast Cancer|July 16, 2020
The Influence of Histologic Grade on Outcomes of Elderly Women With Early Stage Breast Cancer Treated With Breast Conserving Surgery With or Without RadiotherapyChase E Escott, David Zaenger, Jeffrey M Switchencko, et al.Breast Cancer Research : BCR|July 2, 2025
Palazestrant, a novel oral Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD), in patients with ER+/HER2- advanced or metastatic breast cancer: phase 1/2 study resultsErika P Hamilton, Manish R Patel, Virginia F Borges, et al.Breast Cancer Research : BCR|September 4, 2019
A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive breast cancer (TEAL study)Tejal A Patel, Joe E Ensor, Sarah L Creamer, et al.Gynecologic Oncology|January 20, 2023
Predicting outcomes in female germ cell tumors using a modified International Germ Cell Cancer Collaborative Group classification system to guide managementYing L Liu, Beryl L Manning-Geist, Andrea Knezevic, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2025
Circulating tumor cells dynamics after CDK4/6 inhibitor for hormone-receptor positive metastatic breast cancer: a biomarker analysis from the PACE phase II studyLorenzo Gerratana, Carolina Reduzzi, Yue Ren, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2017
Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian CancerBritta Weigelt, Iñaki Comino-Méndez, Ino de Bruijn, et al.Pageof 4